A recent study published in JAMA Network Open found that combining exercise with glucagon-like peptide-1 receptor agonist therapy preserved bone mineral density at key sites during weight loss in adults with obesity.
Study finds insufficient physical activity is a global issue, with nearly a third of adults worldwide not getting adequate amounts of exercise in 2022.
Investigators may have uncovered the real-world incidence rates of severe acute liver injury following the initiation of drugs suspected to be hepatotoxic.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
The World Health Organization has issued warnings about falsified semaglutides used in diabetes and weight-loss drugs, following the detection of altered batches of products in Brazil, the UK, and the U.S.
A recent study published in JAMA Dermatology suggests that older age, higher BMI, and smoking status may be associated with reduced effectiveness of biologic treatments in psoriasis patients.
Nestle introduces Vital Pursuit, a new food brand tailored for people taking weight-loss drugs like Wegovy, focusing on high-protein, nutrient-dense meals while navigating regulatory concerns and competition in the growing market targeting GLP-1 medication users.